RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,836,338 | -63.1% | 80,102 | -71.3% | 0.01% | -53.3% |
Q1 2023 | $4,973,043 | +934.5% | 278,758 | +1588.6% | 0.03% | +900.0% |
Q4 2022 | $480,713 | -82.4% | 16,508 | -85.2% | 0.00% | -80.0% |
Q3 2022 | $2,732,000 | +571.3% | 111,511 | +13.7% | 0.02% | +650.0% |
Q2 2022 | $407,000 | +178.8% | 98,091 | +569.1% | 0.00% | +100.0% |
Q4 2021 | $146,000 | -30.5% | 14,661 | +51.2% | 0.00% | -66.7% |
Q3 2020 | $210,000 | -34.4% | 9,694 | -30.4% | 0.00% | -50.0% |
Q4 2019 | $320,000 | +58.4% | 13,919 | +48.8% | 0.01% | +50.0% |
Q3 2019 | $202,000 | -27.3% | 9,352 | -25.9% | 0.00% | -20.0% |
Q2 2019 | $278,000 | +1.8% | 12,622 | +44.5% | 0.01% | -64.3% |
Q2 2018 | $273,000 | +1087.0% | 8,735 | +642.8% | 0.01% | +1300.0% |
Q1 2018 | $23,000 | -73.6% | 1,176 | -60.7% | 0.00% | -80.0% |
Q4 2017 | $87,000 | – | 2,992 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |